Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei G Vlassenko

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Disease Markers|October 2, 2015
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain TumorsAndrei G Vlassenko, Jonathan McConathy, Lars E Couture, et al.
Neurobiology of Aging|January 3, 2026
Regional growth rates of white matter hyperintensities are associated with beta-amyloid burdenJeremy F Strain, Maryam Rahmani, Chia-Ling Phuah, et al.
JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Brain Imaging and Behavior|July 31, 2024
Evolution of white matter hyperintensity segmentation methods and implementation over the past two decades; an incomplete shift towards deep learningMaryam Rahmani, Donna Dierker, Lauren Yaeger, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Disease Markers|October 2, 2015
Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain TumorsAndrei G Vlassenko, Jonathan McConathy, Lars E Couture, et al.
Neurobiology of Aging|January 3, 2026
Regional growth rates of white matter hyperintensities are associated with beta-amyloid burdenJeremy F Strain, Maryam Rahmani, Chia-Ling Phuah, et al.
JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 9, 2019
Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studiesYi Su, Shaney Flores, Guoqiao Wang, et al.
Brain Imaging and Behavior|July 31, 2024
Evolution of white matter hyperintensity segmentation methods and implementation over the past two decades; an incomplete shift towards deep learningMaryam Rahmani, Donna Dierker, Lauren Yaeger, et al.
Pageof 6